Average annual medical expenses for male cancer survivors were more than double those of men with no history of cancer in 2008-2011, while expenditures for female cancer survivors were 64% higher...
MINNEAPOLIS – People who have the type of insomnia characterized by a sharply shortened duration of sleep are at increased risk for cancer, a longitudinal cohort study showed.
In the study of more...
ORLANDO – Screening men who are at high genetic risk for prostate cancer appears to provide a mortality benefit, according to an analysis of data from a randomized trial.
Of 73,200 men who...
MINNEAPOLIS – Both cognitive behavioral therapy for insomnia and mindfulness-based stress reduction training lessened insomnia in a group of cancer survivors, although the former works faster, new...
ORLANDO – Specially trained dogs accurately detected specific prostate cancer volatile organic compounds in urine samples from patients with varying stages of disease and risk levels in a controlled...
CHICAGO – The investigational targeted agent pembrolizumab induced durable treatment responses in a high percentage of patients with advanced metastatic melanoma, in a phase I study.
Of 411...
CHICAGO – The aromatase inhibitor exemestane is more effective than tamoxifen in preventing breast cancer recurrence in premenopausal women also receiving ovarian function suppression as adjuvant...
CHICAGO –The answer was nearly a decade in coming, but worth the wait: Adding docetaxel to initial hormonal therapy in men with metastatic, hormone-sensitive prostate cancer can extend overall...
CHICAGO – The answer was nearly a decade in coming, but worth the wait: Adding docetaxel to initial hormonal therapy in men with metastatic, hormone-sensitive prostate cancer can extend overall...
CHICAGO – Use of the gonadotropin-releasing hormone agonist goserelin during chemotherapy for early hormone receptor–negative breast cancer was associated with lower rates of ovarian failure and more...
